Characteristics of patients with major depressive disorder eligible for and prescribed esketamine, treatment outcomes and physician experiences: a physician and patient survey in the United States
The substantial impact of TRD and MDSI on daily life and unmet treatment need was underestimated by physicians. Patients treated with esketamine reported favorable outcomes.
Authors
- Nick Grant
- Chloe Middleton‐Dalby (ORCID: https://orcid.org/0000-0001-5470-1329)
- Alexander Gillespie (ORCID: https://orcid.org/0000-0003-2263-1770)
- Jason F. Shepherd (ORCID: https://orcid.org/0000-0002-6959-2628)
- Amanda Teeple
- Manish K. Jha (ORCID: https://orcid.org/0000-0002-2764-2391)
- Sue Kirkman
- Kruti Joshi (ORCID: https://orcid.org/0000-0001-9263-5158)
- Ashley Mortimer
Institutions
- Janssen (Belgium) (BE)
- Adelphi Group (United Kingdom) (GB)
- Southwestern Medical Center (US)
- Janssen (United States) (US)
- Southwestern Medical Center (US)
- Janssen Scientific Affairs (United States)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1080/03007995.2025.2463975
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00